Systems genetics identifies Sestrin 3 as a regulator of a proconvulsant gene network in human epileptic hippocampus

Gene-regulatory network analysis is a powerful approach to elucidate the molecular processes and pathways underlying complex disease. Here we employ systems genetics approaches to characterize the genetic regulation of pathophysiological pathways in human temporal lobe epilepsy (TLE). Using surgically acquired hippocampi from 129 TLE patients, we identify a gene-regulatory network genetically associated with epilepsy that contains a specialized, highly expressed transcriptional module encoding proconvulsive cytokines and Toll-like receptor signalling genes. RNA sequencing analysis in a mouse model of TLE using 100 epileptic and 100 control hippocampi shows the proconvulsive module is preserved across-species, specific to the epileptic hippocampus and upregulated in chronic epilepsy. In the TLE patients, we map the trans-acting genetic control of this proconvulsive module to Sestrin 3 (SESN3), and demonstrate that SESN3 positively regulates the module in macrophages, microglia and neurons. Morpholino-mediated Sesn3 knockdown in zebrafish confirms the regulation of the transcriptional module, and attenuates chemically induced behavioural seizures in vivo.

[1]  Martin Vingron,et al.  A trans-acting locus regulates an anti-viral expression network and type 1 diabetes risk , 2010, Nature.

[2]  S. Horvath,et al.  Integrative Functional Genomic Analyses Implicate Specific Molecular Pathways and Circuits in Autism , 2013, Cell.

[3]  E. Koonin,et al.  Regeneration of Peroxiredoxins by p53-Regulated Sestrins, Homologs of Bacterial AhpD , 2004, Science.

[4]  Patrick F. Sullivan,et al.  Genetic architectures of psychiatric disorders: the emerging picture and its implications , 2012, Nature Reviews Genetics.

[5]  Michael R. Johnson,et al.  Genetic determinants of common epilepsies: a meta-analysis of genome-wide association studies , 2014, The Lancet Neurology.

[6]  G. Sperk,et al.  Powerful anticonvulsant action of IL-1 receptor antagonist on intracerebral injection and astrocytic overexpression in mice. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[7]  M. Hermann,et al.  FOXO3-induced reactive oxygen species are regulated by BCL2L11 (Bim) and SESN3 , 2012, Journal of Cell Science.

[8]  Pak Chung Sham,et al.  Two-stage genome-wide association study identifies variants in CAMSAP1L1 as susceptibility loci for epilepsy in Chinese. , 2012, Human molecular genetics.

[9]  K. Christensen,et al.  Genetic and environmental factors in epilepsy: a population-based study of 11 900 Danish twin pairs , 2001, Epilepsy Research.

[10]  Peter A. M. de Witte,et al.  Validation of the Zebrafish Pentylenetetrazol Seizure Model: Locomotor versus Electrographic Responses to Antiepileptic Drugs , 2013, PloS one.

[11]  P. Ghazal,et al.  Synaptic NMDA receptor activity boosts intrinsic antioxidant defenses , 2008, Nature Neuroscience.

[12]  E. Aronica,et al.  Toll-like receptor 4 and high-mobility group box-1 are involved in ictogenesis and can be targeted to reduce seizures , 2010, Nature Medicine.

[13]  Sarah Baxendale,et al.  Identification of compounds with anti-convulsant properties in a zebrafish model of epileptic seizures , 2012, Disease Models & Mechanisms.

[14]  Cole Trapnell,et al.  TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions , 2013, Genome Biology.

[15]  J. Tsien,et al.  c-fos regulates neuronal excitability and survival , 2002, Nature Genetics.

[16]  Yuanfang Guan,et al.  Tissue-Specific Functional Networks for Prioritizing Phenotype and Disease Genes , 2012, PLoS Comput. Biol..

[17]  Michael R. Johnson,et al.  A genome-wide association study and biological pathway analysis of epilepsy prognosis in a prospective cohort of newly treated epilepsy. , 2014, Human molecular genetics.

[18]  Marc Chadeau-Hyam,et al.  ESS++: a C++ objected-oriented algorithm for Bayesian stochastic search model exploration , 2011, Bioinform..

[19]  J. French,et al.  Interleukin-1β Biosynthesis Inhibition Reduces Acute Seizures and Drug Resistant Chronic Epileptic Activity in Mice , 2011, Neurotherapeutics.

[20]  S. Horvath,et al.  Transcriptomic Analysis of Autistic Brain Reveals Convergent Molecular Pathology , 2011, Nature.

[21]  A. Vezzani,et al.  The role of cytokines in the pathophysiology of epilepsy , 2008, Brain, Behavior, and Immunity.

[22]  E. Oxtoby,et al.  Cloning of the zebrafish krox-20 gene (krx-20) and its expression during hindbrain development. , 1993, Nucleic acids research.

[23]  Sylvia Richardson,et al.  Bayesian Detection of Expression Quantitative Trait Loci Hot Spots , 2011, Genetics.

[24]  M. Newton.  Large-Scale Simultaneous Hypothesis Testing: The Choice of a Null Hypothesis , 2008 .

[25]  A. Vezzani,et al.  Brain Inflammation in Epilepsy: Experimental and Clinical Evidence , 2005, Epilepsia.

[26]  D. Janigro,et al.  Efficacy of Anti-Inflammatory Therapy in a Model of Acute Seizures and in a Population of Pediatric Drug Resistant Epileptics , 2011, PloS one.

[27]  B. Kopnin,et al.  Ras-induced ROS upregulation affecting cell proliferation is connected with cell type-specific alterations of HSF1/SESN3/p21Cip1/WAF1 pathways , 2013, Cell cycle.

[28]  Kathleen A. Kennedy,et al.  Systems biology approaches identify ATF3 as a negative regulator of Toll-like receptor 4 , 2006, Nature.

[29]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[30]  A. Lusis,et al.  Systems genetics approaches to understand complex traits , 2013, Nature Reviews Genetics.

[31]  C. Liou,et al.  Upregulation of nitric oxide synthase II contributes to apoptotic cell death in the hippocampal CA3 subfield via a cytochrome c/caspase-3 signaling cascade following induction of experimental temporal lobe status epilepticus in the rat , 2007, Neuropharmacology.

[32]  Tallie Z. Baram,et al.  The role of inflammation in epilepsy , 2011, Nature Reviews Neurology.

[33]  Mark D. Robinson,et al.  edgeR: a Bioconductor package for differential expression analysis of digital gene expression data , 2009, Bioinform..

[34]  M. Daly,et al.  Proteins Encoded in Genomic Regions Associated with Immune-Mediated Disease Physically Interact and Suggest Underlying Biology , 2011, PLoS genetics.

[35]  G. Teskey,et al.  Postnatal Inflammation Increases Seizure Susceptibility in Adult Rats , 2008, The Journal of Neuroscience.

[36]  T. Baram,et al.  Neuropeptide-mediated excitability: a key triggering mechanism for seizure generation in the developing brain , 1998, Trends in Neurosciences.

[37]  Korbinian Strimmer,et al.  An empirical Bayes approach to inferring large-scale gene association networks , 2005, Bioinform..

[38]  Q. Pittman,et al.  Microglial activation and TNFα production mediate altered CNS excitability following peripheral inflammation , 2008, Proceedings of the National Academy of Sciences.

[39]  M. Mazzuferi,et al.  Rapid epileptogenesis in the mouse pilocarpine model: Video-EEG, pharmacokinetic and histopathological characterization , 2012, Experimental Neurology.

[40]  C. Gieger,et al.  Genome-wide association analysis of genetic generalized epilepsies implicates susceptibility loci at 1q43, 2p16.1, 2q22.3 and 17q21.32. , 2012, Human molecular genetics.

[41]  A. Butte,et al.  Leveraging models of cell regulation and GWAS data in integrative network-based association studies , 2012, Nature Genetics.

[42]  E. Esposito,et al.  Molecular and functional interactions between tumor necrosis factor-alpha receptors and the glutamatergic system in the mouse hippocampus: Implications for seizure susceptibility , 2009, Neuroscience.

[43]  Scott C. Baraban,et al.  Drug screening in Scn1a zebrafish mutant identifies clemizole as a potential Dravet Syndrome treatment , 2013, Nature Communications.

[44]  L. Tran,et al.  Integrated Systems Approach Identifies Genetic Nodes and Networks in Late-Onset Alzheimer’s Disease , 2013, Cell.

[45]  J. Sandkühler,et al.  Neurogenic neuroinflammation: inflammatory CNS reactions in response to neuronal activity , 2013, Nature Reviews Neuroscience.

[46]  Ivan Molineris,et al.  An atlas of tissue-specific conserved coexpression for functional annotation and disease gene prediction , 2011, European Journal of Human Genetics.

[47]  Michael R. Johnson,et al.  Describing the genetic architecture of epilepsy through heritability analysis , 2014, Brain : a journal of neurology.

[48]  B. Efron.  Large-Scale Simultaneous Hypothesis Testing , 2004 .

[49]  A. Vezzani,et al.  Status epilepticus induces time-dependent neuronal and astrocytic expression of interleukin-1 receptor type I in the rat limbic system , 2006, Neuroscience.

[50]  Michael R. Johnson,et al.  Common genetic variation and susceptibility to partial epilepsies: a genome-wide association study , 2010, Brain : a journal of neurology.

[51]  De novo mutations in epileptic encephalopathies , 2013 .

[52]  J. Meyer,et al.  Univariate genetic analyses of epilepsy and seizures in a population‐based twin study: The Virginia twin registry , 1998, Genetic epidemiology.

[53]  N. Hay,et al.  Akt determines replicative senescence and oxidative or oncogenic premature senescence and sensitizes cells to oxidative apoptosis. , 2008, Cancer cell.

[54]  P. Chauvel,et al.  Epileptogenicity of brain structures in human temporal lobe epilepsy: a quantified study from intracerebral EEG. , 2008, Brain : a journal of neurology.

[55]  Zhi-jun Zhang,et al.  Chemokine CXCL1 enhances inflammatory pain and increases NMDA receptor activity and COX-2 expression in spinal cord neurons via activation of CXCR2 , 2014, Experimental Neurology.

[56]  Michael R. Taylor,et al.  Pentylenetetrazole induced changes in zebrafish behavior, neural activity and c-fos expression , 2005, Neuroscience.

[57]  E. Aronica,et al.  The IL-1β system in epilepsy-associated malformations of cortical development , 2006, Neurobiology of Disease.

[58]  K. Akgün-Dar,et al.  Erythropoietin pretreatment suppresses seizures and prevents the increase in inflammatory mediators during pentylenetetrazole-induced generalized seizures , 2014, The International journal of neuroscience.